Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound

Robert Carlisle1, James Choi, Miriam Bazan-Peregrino

  • 1Affiliations of authors: Institute of Biomedical Engineering, Department of Engineering Science(RC, JC, C-CC) and Department of Oncology (RL, LWS), University of Oxford, Oxford, UK; Institut d'Investigacio Biomedica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain (MB-P); Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic (VS, LK, KU).

Abstract

Insights

Polymer-coating improved adenovirus (Ad) delivery for cancer treatment. Combining stealth Ad with ultrasound and microbubbles enhanced tumor infection and survival in mice.

Area of Science:

  • Oncolytic virotherapy
  • Nanomedicine
  • Biotechnology

Background:

  • Oncolytic viruses show promise for cancer therapy, especially with direct tumor injection.
  • Intravenous delivery for metastatic disease is limited by poor pharmacokinetics and tumor penetration.

Purpose of the Study:

  • To improve intravenous delivery and tumor penetration of oncolytic viruses.
  • To enhance the efficacy of adenovirus (Ad) for treating metastatic cancer.

Main Methods:

  • Adenovirus was coated with a polymer (N-(2-hydroxypropyl)methacrylamide) to create a
  • stealthed
  • Ad.
  • Mice bearing human xenograft tumors received polymer-coated Ad, gas microbubbles, and focused ultrasound.
  • Ultrasound-induced inertial cavitation was used to enhance drug extravasation and tumor penetration.

Main Results:

  • Polymer-coating significantly reduced liver sequestration and toxicity, and increased circulation half-life (>50-fold).
  • The combination therapy enhanced tumor infection (>30-fold) and enabled deeper tumor cell kill (>100 microns from blood vessels).
  • This approach led to significant tumor growth retardation and increased survival.

Conclusions:

  • Combining polymer-based drug
  • stealthing
  • with ultrasound-induced cavitation can improve therapeutic delivery.
  • This strategy holds potential for enhancing the efficacy of oncolytic viruses and treating metastatic cancers.